Analysts set USD 21.50 target for Sotera Health stock

Published on 10/01/2026 at 21:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 9.20 percent year over year to USD 321.38 million in the second quarter. Sotera Health stock costs EUR 16.25 after EUR 16.35 on October 1, 2026.

SHC, US83601L1026, Illustration mit AI erstellt.

Sotera Health (ISIN US83601L1026) was trading at EUR 16.25 at Lang & Schwarz on October 1, 2026 at 9:36 p.m. CEST, down 0.61 percent versus the prior close of EUR 16.35. According to MarketBeat on September 25, 2026, the average 12-month analyst target was USD 21.50, with eight of 11 analysts rating the stock a buy.

Analysts see room above USD 21.50

The analyst view sets a clear valuation reference while the euro quotation remains below its previous Lang & Schwarz close. MarketBeat also reported that Barclays raised its target from USD 19.00 to USD 22.00 on August 7, 2026, while Piper Sandler set a USD 25.00 target on September 8, 2026.

The target spread shows that estimates are not uniform. The average target of USD 21.50 stands USD 3.26 above the Nasdaq quote of USD 18.24 from October 1, 2026, a difference of 17.97 percent calculated in US dollars.

Second-quarter revenue reaches USD 321.38 million

Sotera Health reported second-quarter 2026 net revenue of USD 321.38 million, up 9.20 percent from the second quarter of 2025. Net income reached USD 54.00 million, compared with USD 8.00 million in the year-earlier quarter, while diluted earnings per share came to USD 0.19.

The operating picture also improved in the quarter. Operating profit was USD 106.79 million and the operating margin was 33.00 percent, compared with USD 75.83 million and 27.00 percent in the first quarter of 2026.

At a September 9, 2026 healthcare conference, Investing.com reported that management expected 2026 capital spending of USD 200 million to USD 225 million and 20 to 25 basis points of additional EBITDA margin improvement. The spending level is tied to compliance upgrades, Cobalt-60 development and new sterilization capacity.

Stock remains below its Nasdaq high

On Nasdaq, Sotera Health was trading at USD 18.24 on October 1, 2026 at 3:40 p.m. ET. The finance snapshot put the company at a USD 5.2 billion market capitalization, with a 52-week Nasdaq range of USD 13.09 to USD 19.85.

Wallstreet Online lists Nasdaq as the primary exchange and November 3, 2026 as the next quarterly reporting date. The combination of second-quarter growth, planned capital spending and analyst targets gives the stock three measurable reference points for the next report.

Lang & Schwarz price on October 1

Sotera Health was trading at EUR 16.25 at Lang & Schwarz on October 1, 2026 at 9:36 p.m. CEST, down 0.61 percent versus the Lang & Schwarz prior close of EUR 16.35.